The InGaZnO thin films are fabricated on the quartz glass using pulsed laser deposition (PLD), where the target is prepared by mixing the Ga₂O₃, In₂O₃, and ZnO powders at a mol ratio of 1:1:8 before the solid-state reactions in a tube furnace at the atmospheric pressure. The product thin films were characterized comprehensively by X-ray diffraction, atomic force microscopy, Hall-effect investigation, and X-ray photoelectron spectroscopy. Thus, we demonstrate semiconductor thin-film materials with high smoothness, high transmittance in visible region, and excellent electrical properties.

A random fiber laser is achieved based on the plasmonic feedback mechanism, which is constructed by first siphoning the polymer solution doped with silver nanoparticles into a 300-μm capillary tube and then evaporating the solvent. Strong amplification of the radiation can be obtained by employing the variable gain region, the fiber waveguide scheme and three-dimensional plasmonic feedback provided by the silver nanoparticles. Low-threshold directional random lasing is observed in the polymer fiber. This simple and straightforward approach facilitates the investigation of plasmonic random fiber lasers.

A random laser on the optical fiber facet is constructed by dipping an optical fiber end face into the solution of polydimethylsiloxane doped with rhodamine 6G organic dye and silver nanowires. The PDMS film doped with rhodamine 6G acts as the active waveguide layer, and the silver nanowires provide a three-dimensional plasmonic feedback. The plasmon resonance of silver nanowires significantly improves the pump efficiency of the random laser. The most output energy of random laser concentrates in a small angle range along the axis of the optical fiber. This fabrication technique provides a simple and efficient way for the fabrication of random lasers on the optical fiber facet with low cost.

Micro targeted therapy for cancer has become a hot topic in recent years because of its advantages of little damage to the human body and early treatment of cancer.